Re:Biohackers take aim at big pharma’s stranglehold on insulin
by jjmarinho on Monday June 28, 2021 @10:18PM
(#27670947)
It's still the wrong question to ask.
We should ask what are the outcomes that these systems produce, not how new the drugs are.
A cutting-edge healthcare system plagued by inequality and extreme costs can produce worse results than a more efficient healthcare system which is not as high-tech.
We should ask what are the outcomes that these systems produce, not how new the drugs are.
A cutting-edge healthcare system plagued by inequality and extreme costs can produce worse results than a more efficient healthcare system which is not as high-tech.